Governance designed for efficiency and flexibility
Paris Brain Institute chose a governance structure that is built on a strong partnership between the public and private sectors, as reflected in the membership of its board of directors and management committees. They ensure that the Paris Brain Institute structure and resources are matched to its scientific goals. By implementing controls to ensure efficient management and regularly assessing the progress and performance of teams, its management team guarantees continued excellence. Paris Brain Institute adheres to a policy of full transparency with respect to its partners and publicly discloses information about its responsibilities and results in its annual report.
Board of Directors
College of the founders
- Gérard Saillant, President
- Jean Todt, Vice-President,
- Serge Weinberg, President of Weinberg Capital Partners, Treasurer of Paris Brain Institute
- Jean Glavany, Former Minister
- Jean-Pierre Martel, Attorney
College of qualified personalities
- Philippe Menasché, Professor of Thoracic and Cardiovascular Surgery at Univerité de Paris
- Richard Frackowiak, Emeritus Professor at University College London
- Elisabeth Tournier-Lasserve, Professor of medical genetics at Université de Paris
College of full members
- Bernard Poulain, Scientific deputy director of INSB and representative of the National Center for Scientific Research (CNRS)
- Didier Samuel, representative of the National Institute for Health and Medical Research (INSERM)
- Bruno Riou, Dean and representative of Sorbonne University
- Nicolas Revel, Director of Relations with Universities and Research Organisations and representative of Paris Hospital Administration (AP-HP)
College of the Friends of the Foundation
- Maurice Lévy
- Christian Schmidt de la Brélie
- Martine Assouline
Government Commissioner
- Jean-Marie Paulot
Scientific Advisory Board
Pr Dimitri Kullmann — Président, Clinical & Experimental Epilepsy UCL Queen Square Institute of Neurology, Royaume-Uni
Pr Christian Buchel, Institut für Systemische Neurowissenschaften Universitätsklinikum – Hamburg, Allemagne
Pr Adrienne Fairhall, Department of Physiology and Biophysics, Department of Physics and Department of Applied Mathematics, Washington University, USA
Pr Tamas Gabor, University of Szeged, Department of Physiology, Anatomy and Neuroscience, Hongrie
Pr Magdalena Goetz, LMU Department of Physiological Genomics Helmholz Center Munich, Institute Stem Cell Research, Allemagne
Pr Masud Husain, Wellcome Trust Principal Fellow ‐ Nuffield Dept Clinical Neuroscience -University of Oxford, Royaume-Uni
Pr Sabine Kastner, Princeton Neuroscience Institute, USA
Pr Giovanna Malluci, Department of Clinical Neurosciences, University of Cambridge, Royaume-Uni
Pr Eve Marder, Victor and Gwendolyn Beinfield, Brandeis University, USA
Pr Carmen Sandi, Laboratory of Behavioral Genetics ‐ Brain Mind Institute – EPFL de Lausanne, Suisse
Pr Erin Schuman, Goethe University Frankfurt, Allemagne
Pr Mikael Simons, Institute of Neuronal Cell Biology (TUM‐NCB) Technical University Munich German Center for Neurodegenerative Diseases (DZNE), Germany
Audit Committee
The Audit Committee helps the Board of Directors oversee the management of the foundation as concerns financial information, accounting, risk management and investment policy.
The members of the Audit Committee are:
- Mr. Serge Weinberg, President;
- Mrs. Claire Giry ;
- Mr. Jean Glavany;
- Mr. Jean-Pierre Martel.
Management committee
The Executive Management carries out the policy defined by the Board of Directors of Paris Brain Institute. The Director General, named by the Board of Directors, directs a Steering Committee composed of 5 members.
Pr. Alexis Brice, Executive Director of Paris Brain Institute and the Joint Research Unit (UMR)
Dr Brian Lau, Scientific director, Platforms director and Deputy UMR Director
Pr Catherine Lubetzki, Medical Director
Corinne Fortin, Secretary General of Paris Brain Institute and the Joint Research Unit (UMR)
Jean-Louis Da Costa, Director of Communication and Development